Mani Inc
TSE:7730

Watchlist Manager
Mani Inc Logo
Mani Inc
TSE:7730
Watchlist
Price: 1 790 JPY -0.72% Market Closed
Market Cap: ¥176.3B

P/B

3.1
Current
10%
Cheaper
vs 3-y average of 3.4

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
3.1
=
Market Cap
¥183.7B
/
Total Equity
¥56.7B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
3.1
=
Market Cap
¥183.7B
/
Total Equity
¥56.7B

Valuation Scenarios

Mani Inc is trading below its 3-year average

If P/B returns to its 3-Year Average (3.4), the stock would be worth ¥1 979.07 (11% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-55%
Maximum Upside
+19%
Average Downside
15%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 3.1 ¥1 790
0%
3-Year Average 3.4 ¥1 979.07
+11%
5-Year Average 3.7 ¥2 129.6
+19%
Industry Average 2 ¥1 131.96
-37%
Country Average 1.4 ¥812.89
-55%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
JP
Mani Inc
TSE:7730
176.3B JPY 3.1 23.5
US
Medline Inc
NASDAQ:MDLN
58.8B USD 0 0
JP
Hoya Corp
TSE:7741
9.7T JPY 9.4 38.6
CH
Alcon AG
SIX:ALC
29.2B CHF 1.7 37.3
DK
Coloplast A/S
CSE:COLO B
94.7B DKK 6.8 23.5
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 3.3 33
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 3.8 32.7
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 0.9 -15.5
JP
Asahi Intecc Co Ltd
TSE:7747
890.2B JPY 5.6 50.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
36.7B CNY 4.4 23.3
KR
HLB Inc
KOSDAQ:028300
8T KRW 19.1 -36.2
P/E Multiple
Earnings Growth PEG
JP
Mani Inc
TSE:7730
Average P/E: 32.8
23.5
22%
1.1
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.6
15%
2.6
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
33
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
32.7
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.5 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.3
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
9%
2.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.2 N/A N/A

Market Distribution

Higher than 82% of companies in Japan
Percentile
82st
Based on 5 195 companies
82st percentile
3.1
Low
0 — 1.1
Typical Range
1.1 — 2.1
High
2.1 —
Distribution Statistics
Japan
Min 0
30th Percentile 1.1
Median 1.4
70th Percentile 2.1
Max 31 732 017.6

Mani Inc
Glance View

Market Cap
176.3B JPY
Industry
Health Care

In the dynamic landscape of modern manufacturing, Mani Inc. emerges as a pivotal player, weaving together innovation and tradition in the realm of precision tools. Founded in the late 20th century, the company quickly distinguished itself by specializing in the design and production of high-quality dental and medical instruments. At its core, Mani Inc. thrives on its commitment to quality and reliability, underpinning its operations with cutting-edge technology and meticulous craftsmanship. Boasting a global presence, the company navigates a complex supply chain and adheres to stringent regulatory standards, ensuring its tools meet the diverse needs of practitioners around the world. Mani Inc. engages directly with dental professionals and healthcare institutions, building lasting relationships that are strengthened by the consistent performance and longevity of its products. Economically, Mani Inc. capitalizes on its expansive distribution network and brand loyalty to generate revenue, with a business model that focuses on both direct sales and partnerships with distributors. This approach allows the company not only to reach a wide array of international markets but also to tailor its offerings to specific regional demands. Its commitment to research and development propels innovation that further solidifies its market position, helping to safeguard against the fluctuations that often characterize the medical tools segment. By investing significantly in R&D, Mani Inc. ensures its product lineup remains at the forefront of technology and efficiency, thereby reinforcing its competitive edge in an industry where precision is paramount.

Intrinsic Value
1 476.99 JPY
Overvaluation 17%
Intrinsic Value
Price ¥1 790
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett